HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beatrix Bálint Selected Research

Anemia

3/2013A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beatrix Bálint Research Topics

Disease

4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 03/2013
3Asthma (Bronchial Asthma)
09/2015 - 08/2012
2Neoplasms (Cancer)
01/2018 - 03/2013
2Exanthema (Rash)
07/2015 - 03/2015
2Disease Progression
07/2015 - 03/2015
1Acne Vulgaris
07/2015
1Allergic Rhinitis
07/2014
1Thrombocytopenia (Thrombopenia)
03/2013
1Neutropenia
03/2013
1Anemia
03/2013

Drug/Important Bio-Agent (IBA)

3necitumumabIBA
01/2018 - 03/2015
2Air Pollutants (Pollutants, Air)IBA
09/2015 - 08/2012
2Cisplatin (Platino)FDA LinkGeneric
07/2015 - 03/2015
2Environmental Pollutants (Pollutants, Environmental)IBA
07/2014 - 08/2012
1ErbB Receptors (EGF Receptor)IBA
01/2018
1GemcitabineFDA Link
07/2015
1AntibodiesIBA
07/2015
1Pemetrexed (MTA)FDA Link
03/2015
1Carboplatin (JM8)FDA LinkGeneric
03/2013
1Paclitaxel (Taxol)FDA LinkGeneric
03/2013
1conatumumabIBA
03/2013

Therapy/Procedure

3Therapeutics
01/2018 - 03/2015
2Drug Therapy (Chemotherapy)
07/2015 - 03/2015